An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
Clinical trial NCT00632736 · COMPLETED
Trial details
- NCT number
- NCT00632736
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2010-03-01
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.